Verónica F. V. Prazeres

发表

A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.

J. Otero, A. Hawkins, C. González‐Bello, 2011, Journal of medicinal chemistry.

2‐Substituted‐3‐Dehydroquinic Acids as Potent Competitive Inhibitors of Type II Dehydroquinase

A. Hawkins, C. González‐Bello, L. Castedo, 2009, ChemMedChem.

Stereoselective Synthesis of Novel Cyclic γ-Amino Acids and Triazole Derivatives†

C. González‐Bello, L. Castedo, Verónica F. V. Prazeres, 2008 .

Understanding the Key Factors that Control the Inhibition of Type II Dehydroquinase by (2R)‐2‐Benzyl‐3‐dehydroquinic Acids

J. Otero, F. Gago, A. Hawkins, 2010, ChemMedChem.

Competitive Inhibitors of Helicobacter pylori Type II Dehydroquinase: Synthesis, Biological Evaluation, and NMR Studies

A. Hawkins, C. González‐Bello, S. Suh, 2008, ChemMedChem.

Determination of the Bound Conformation of a Competitive Nanomolar Inhibitor of Mycobacterium tuberculosis Type II Dehydroquinase by NMR Spectroscopy

A. Hawkins, C. González‐Bello, F. Cañada, 2006, ChemMedChem.

Mechanistic basis of the inhibition of type II dehydroquinase by (2S)- and (2R)-2-benzyl-3-dehydroquinic acids.

J. Otero, A. Hawkins, C. González‐Bello, 2013, ACS chemical biology.

Nanomolar Competitive Inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor Type II Dehydroquinase

J. Coggins, A. Hawkins, C. González‐Bello, 2007, ChemMedChem.

Structure-based design, synthesis, and biological evaluation of inhibitors of Mycobacterium tuberculosis type II dehydroquinase.

A. Hawkins, C. González‐Bello, L. Castedo, 2005, Journal of medicinal chemistry.